Products
Online Inquiry
Rotundic acid
Cat. No.:
0225LY-0607
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Rotundic acid is a natural substance that demonstrates cytotoxic effects against several cancer cell lines, including those of the colon (HT-29), breast (MCF-7), small cell lung (NCI-H446), melanoma (A375), and liver (HepG2).
Synonym:
20137-37-5; (1R,2R,4aS,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-1,10-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; Urs-12-en-28-oic acid, 3,19,23-trihydroxy-, (3beta,4alpha)-; 22-Deoxyilexolic acid A
CAS No.:
20137-37-5
Compound CID:
12315075
Formula:
C30H48O5
Formula Weight:
488.7
Specification
Relative Density:
1.19 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Rotundic acid can be used in natural product research to explore its potential anti-inflammatory and lipid-lowering biological activities.
Library Information
Target:
Akt; mTOR; p38 MAPK
Receptor:
Akt; mTOR; p38 MAPK
Pathways:
MAPK; PI3K/Akt/mTOR signaling; Cytoskeletal signaling; Apoptosis
Plate Number:
AOCL-8
Plate Location:
h2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
245.00 mg/mL; 501.33 mM
